Comparative Evaluation of Epinephrine and Norepinephrine in FluidRefractory Septic Shock in Children: A Randomized Clinical Study in a Tertiary Care Centre
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Fluid-refractory septic shock remains a major cause of morbidity and mortality among children, particularly in low- and middle-income countries. Current paediatric sepsis guidelines recommend early initiation of vasoactive agents such as epinephrine or norepinephrine when shock persists despite adequate fluid resuscitation. However, comparative regarding the efficacy and safety of these agents in children remains limited. Objectives: To compare the efficacy and safety of epinephrine and norepinephrine in children with fluidrefractory septic shock. Methods: This open-label randomized clinical study was conducted in the paediatric intensive care unit of a tertiary care hospital. Children aged 2 months to 12 years with fluid-refractory septic shock, defined according to international paediatric sepsis consensus criteria⁸, were randomized to receive either epinephrine or norepinephrine as the initial vasoactive agent. The primary outcome was resolution of shock at one hour. Secondary outcomes included achievement of therapeutic endpoints at 6, 24, 48, and 72 hours, adverse events, duration of hospital stay, and in-hospital mortality. Results: A total of 54 children were enrolled, with 27 patients in each group. Shock resolution at one hour was achieved in 59.2% of children in the norepinephrine group and 51.8% in the epinephrine group, with no statistically significant difference. There were no significant differences between the groups in achievement of therapeutic endpoints, incidence of adverse events, duration of hospital stay, or mortality. Tachycardia was the most commonly observed adverse event in both groups. Conclusion: Epinephrine and norepinephrine demonstrated comparable efficacy and safety in the management of paediatric fluid-refractory septic shock. These findings support current guideline recommendations endorsing the use of either agent as first-line vasoactive therapy³, with selection guided by clinical context and resource availability.
Fields of Study & Subjects
Sepsis Diagnosis and Treatment
Hemodynamic Monitoring and Therapy
Abdominal Surgery and Complications
Publication details
- Journal / source
- International Journal of Current Pharmaceutical Review and Research
- Volume
- 18
- Issue
- 03
- Publication date
- 15 March 2026
- Language
- EN